Alprazolam ODT C-IV
- Product NDC
- 72189-637
- 11-digit product format
- 721890637
- Labeler code
- 72189
- Product ID
- 72189-637_4d3aab18-54e7-cb65-e063-6394a90a9b26
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Alprazolam ODT C-IV
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Labeler
- Direct_Rx
- Application
- ANDA078088
- Marketing category
- ANDA
- Marketing start
- 2025-08-22
- Substance
- ALPRAZOLAM
- Active strength
- .5 mg/1
- Pharmacologic classes
- Benzodiazepine [EPC], Benzodiazepines [CS]
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A078088-001 | ALPRAZOLAM | ALPRAZOLAM | 0.25MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | |
| A078088-002 | ALPRAZOLAM | ALPRAZOLAM | 0.5MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | |
| A078088-003 | ALPRAZOLAM | ALPRAZOLAM | 1MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | RS | 2009-01-09 |
| A078088-004 | ALPRAZOLAM | ALPRAZOLAM | 2MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A078088-001 | AB |
| A078088-002 | AB |
| A078088-003 | AB |
| A078088-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A078088-001 | ALPRAZOLAM | 0.25MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A078088-002 | ALPRAZOLAM | 0.5MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | 84e616aacf4f… | |
| 2026-09-14 22:38:34 | 2026-08 | A078088-003 | ALPRAZOLAM | 1MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | RS | 2009-01-09 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A078088-004 | ALPRAZOLAM | 2MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | 84e616aacf4f… | |
| 2026-08-18 06:07:40 | 2026-07 | A078088-001 | ALPRAZOLAM | 0.25MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A078088-002 | ALPRAZOLAM | 0.5MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | caaa826d4ba7… | |
| 2026-08-18 06:07:40 | 2026-07 | A078088-003 | ALPRAZOLAM | 1MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | RS | 2009-01-09 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A078088-004 | ALPRAZOLAM | 2MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | caaa826d4ba7… | |
| 2026-02-19 14:30 UTC | 2026-02 | A078088-001 | ALPRAZOLAM | 0.25MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A078088-002 | ALPRAZOLAM | 0.5MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A078088-003 | ALPRAZOLAM | 1MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | RS | 2009-01-09 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A078088-004 | ALPRAZOLAM | 2MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078088-001 | ALPRAZOLAM | 0.25MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078088-002 | ALPRAZOLAM | 0.5MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078088-003 | ALPRAZOLAM | 1MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | RS | 2009-01-09 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078088-004 | ALPRAZOLAM | 2MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A078088-001 | ALPRAZOLAM | 0.25MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A078088-002 | ALPRAZOLAM | 0.5MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A078088-003 | ALPRAZOLAM | 1MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | RS | 2009-01-09 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A078088-004 | ALPRAZOLAM | 2MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078088-001 | ALPRAZOLAM | 0.25MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078088-002 | ALPRAZOLAM | 0.5MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078088-003 | ALPRAZOLAM | 1MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | RS | 2009-01-09 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078088-004 | ALPRAZOLAM | 2MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078088-001 | ALPRAZOLAM | 0.25MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078088-002 | ALPRAZOLAM | 0.5MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078088-003 | ALPRAZOLAM | 1MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | RS | 2009-01-09 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078088-004 | ALPRAZOLAM | 2MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078088-001 | ALPRAZOLAM | 0.25MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078088-002 | ALPRAZOLAM | 0.5MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078088-003 | ALPRAZOLAM | 1MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | RS | 2009-01-09 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078088-004 | ALPRAZOLAM | 2MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078088-001 | ALPRAZOLAM | 0.25MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078088-002 | ALPRAZOLAM | 0.5MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078088-003 | ALPRAZOLAM | 1MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | RS | 2009-01-09 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078088-004 | ALPRAZOLAM | 2MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078088-001 | ALPRAZOLAM | 0.25MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078088-002 | ALPRAZOLAM | 0.5MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078088-003 | ALPRAZOLAM | 1MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | RS | 2009-01-09 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078088-004 | ALPRAZOLAM | 2MG | TABLET, ORALLY DISINTEGRATING / ORAL | AB | 2009-01-09 | 5bbf6a4d5a75… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-09-14 22:38:34 | 2026-08 | A078088-001 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A078088-002 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A078088-003 | AB | 1 | 84e616aacf4f… |
| 2026-09-14 22:38:34 | 2026-08 | A078088-004 | AB | 1 | 84e616aacf4f… |
| 2026-08-18 06:07:40 | 2026-07 | A078088-001 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A078088-002 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A078088-003 | AB | 1 | caaa826d4ba7… |
| 2026-08-18 06:07:40 | 2026-07 | A078088-004 | AB | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A078088-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A078088-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A078088-003 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A078088-004 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078088-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078088-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078088-003 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A078088-004 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A078088-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A078088-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A078088-003 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A078088-004 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078088-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078088-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078088-003 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A078088-004 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078088-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078088-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078088-003 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A078088-004 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078088-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078088-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078088-003 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A078088-004 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078088-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078088-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078088-003 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A078088-004 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078088-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078088-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078088-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A078088-004 | AB | 1 | 5bbf6a4d5a75… |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Alprazolam ODT C-IV
- Listing expiration
- 2027-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ALPRAZOLAM | .5 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| YU55MQ3IZY | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 485415 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 3cf95203-c8b4-9f06-e063-6394a90abc9c | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| a62a50ac-1535-4461-9768-8ae703e2e9fb | Product name | 1 | 20210525 |
| 2ffbe5ef-58ff-88b9-e291-045e0f861f4f | Product name | 4 | 20180827 |
| 1f9e6d58-49d3-d9c1-e570-4bb0466a2c0b | Product name | 1 | 20140508 |
| 9514609b-a2a9-f8ec-6ba6-3f8e5ee89877 | Product name | 1 | 20140508 |
| a1a11520-f3e2-68fa-8bd9-e80b271ef797 | Product name | 1 | 20140508 |
| bc07ef78-e82d-0c19-31f4-31f263780582 | Product name | 1 | 20140508 |
| d153678e-a3c8-bad8-cfe0-385656dde0e7 | Product name | 1 | 20140508 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72189-637-02 | Alprazolam ODT C-IV | 2 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 2 | 2 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72189-637-02 | EA - Each | 72189-637 | 4d51c7b1-9537-4780-8193-238944ff3c5b | 1 | 2025-10-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Alprazolam | ALPRAZOLAM | Par Health USA, LLC | ff1630b4-2044-433c-96bc-0bb4ae8d42a0 | 2026-04-15 | Boxed warning, Warnings, Adverse reactions | 078088 ANDA078088 |
| Alprazolam ODT C-IV | ALPRAZOLAM ODT C-IV | Direct_Rx | 3cf95203-c8b4-9f06-e063-6394a90abc9c | 2026-03-17 | Boxed warning, Warnings, Adverse reactions | 078088 ANDA078088 72189-637 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 485415 | ALPRAZolam 0.5 MG Disintegrating Oral Tablet | PSN | 3cf95203-c8b4-9f06-e063-6394a90abc9c | 2 |
| 485415 | alprazolam 0.5 MG Disintegrating Oral Tablet | SCD | 3cf95203-c8b4-9f06-e063-6394a90abc9c | 2 |
Packages#
| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|
| 72189-637-02 | 72189063702 | 2 TABLET, ORALLY DISINTEGRATING in 1 CARTON (72189-637-02) | 2025-08-22 | No | No | Current |